HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher D Sherman Selected Research

64Cu-CB-TE2A-sst2-ANT

11/2008Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher D Sherman Research Topics

Disease

3Neoplasms (Cancer)
03/2011 - 04/2008
1Prostatic Neoplasms (Prostate Cancer)
03/2011
1Nephrogenic Fibrosing Dermopathy
11/2010
1Renal Insufficiency (Renal Failure)
11/2010
1Colorectal Neoplasms (Colorectal Cancer)
04/2008
1Carcinogenesis
04/2008

Drug/Important Bio-Agent (IBA)

1Bombesin Receptors (Bombesin Receptor)IBA
03/2011
1Peptides (Polypeptides)IBA
03/2011
1BombesinIBA
03/2011
1bombesin (7-14)IBA
03/2011
1GadoliniumIBA
11/2010
1GD3 ganglioside (GD(3))IBA
11/2010
1Contrast MediaIBA
11/2010
1IonsIBA
11/2010
164Cu-CB-TE2A-sst2-ANTIBA
11/2008
1RadiopharmaceuticalsIBA
11/2008
1n-hexadecaneIBA
11/2008
1Biological ProductsIBA
11/2008
164Cu-CB-TE2A-Y3-TATEIBA
11/2008
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2008
1Somatostatin Receptors (Somatostatin Receptor)IBA
11/2008
1ErbB Receptors (EGF Receptor)IBA
04/2008
164Cu-DOTA-cetuximabIBA
04/2008
1Cetuximab (Erbitux)FDA Link
04/2008
1Monoclonal AntibodiesIBA
04/2008
1LigandsIBA
04/2008